| 2010-06-01 |
Competitor Analysis: CMV Vaccines and Therapeutics |
La Merie S.L. |
| 2010-05-01 |
Competitor Analysis: RSV Vaccines and Therapeutics |
La Merie S.L. |
| 2008-09-01 |
The Future of RNAi Therapeutics: Drug Pipelines and Prospects |
Business Insights |
| 2008-01-31 |
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery |
Decision Resources |
| 2007-11-01 |
RNAi Therapeutics 2008 |
Select Biosciences Limited |
| 2007-07-13 |
Drug Discovery Tools for High-Content Analysis |
Trimark Publications |
| 2007-07-01 |
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes |
CHI Insight Pharma Reports |
| 2007-06-01 |
Outlook For Rnai, 2007: Sirna And Mirna In Biology, Diagnostics And Therapeutics |
Business Insights |
| 2007-04-01 |
High Content Analysis 2007 |
Select Biosciences Limited |
| 2007-02-01 |
RNAi/Nicro RNA Market Report |
Select Biosciences Limited |
| 2006-12-01 |
Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry |
BioInformatics, LLC |
| 2006-10-03 |
Biologic Drugs To Drive Pharmaceutical Market Growth |
Datamonitor |
| 2006-07-20 |
Gene Silencing with RNA Interference: A New Generation of Pharmaceuticals? |
Patent Insights, Inc. |
| 2005-10-01 |
RNAi Therapeutics: Challenges in Drug Development and Delivery |
CHI Insight Pharma Reports |
| 2005-05-01 |
The Outlook For RNAi: Accelerating Drug Discovery And The Development Of RNAi Therapeutics |
Business Insights |
| 2005-01-01 |
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications |
Kalorama Information |
| 2004-04-02 |
Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets |
Frost & Sullivan |
| 2004-04-01 |
U.S. Market for Synthetic Oligonucleotides: Establishing Differentiation for Success |
BioInformatics, LLC |
| 2004-03-01 |
High-Content Analysis Market Outlook |
CHI Insight Pharma Reports |
| 2003-08-22 |
Antivirals-A broad market overview |
Datamonitor |
